Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

To expand on this, Chris Morneau stated yesterday when taking about completion date:

"whether that be September 15 or September 30th" - Chris M.

That completely is inline with my math of September 25th for last patient enrolled. He then said this:

"There is 2 weeks of treatment for that patient, and then a 2 week followup. Then the study closes, and then I would estimate somewhere is the 3 week range for data to be reviewed, there is an audit of the data, then the company gets that data and then we do a data readout " - Chris M.

So 7 week minimum* after last patient enrolled.

September 25 (ish) + 49 days = November 13th.

Now we wait, around 84 days from now.

Second week of November.

B. O. B.